Gara Jalqabaatti › Darmaatomiyoosiitisiis
Qorannoo klinikaalii Darmaatomiyoosiitisiis Ameerikaa Keessatti hirmaatuu
Qorannoo 26 Darmaatomiyoosiitisiis f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Durham, NCQorannoo 8
- Washington, DCQorannoo 7
- New York City, NYQorannoo 5
- Boston, MAQorannoo 5
- Pittsburgh, PAQorannoo 5
- Houston, TXQorannoo 5
- Miami, FLQorannoo 4
- Philadelphia, PAQorannoo 4
- Baltimore, MDQorannoo 4
- Aurora, COQorannoo 3
- Kansas City, KSQorannoo 3
- Jacksonville, FLQorannoo 3
- Phoenix, AZQorannoo 3
- Cleveland, OHQorannoo 3
- New Haven, CTQorannoo 3
Naannoon
- ArizonaQorannoo 4
- CaliforniaQorannoo 9
- ColoradoQorannoo 4
- ConnecticutQorannoo 3
- FloridaQorannoo 7
- IllinoisQorannoo 3
- KansasQorannoo 4
- MarylandQorannoo 9
- MassachusettsQorannoo 5
- New YorkQorannoo 6
- North CarolinaQorannoo 8
- OhioQorannoo 5
- PennsylvaniaQorannoo 7
- TexasQorannoo 6
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07111065Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345Environmental Risk Factors for the Anti-synthetase Syndrome
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 2 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT01276470Adult and Juvenile Myositis
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 2 hanga 100 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT00017914Natural History of Inflammatory Muscle Diseases
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 2 hanga 120 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT05738824A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06455449RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 6 hanga 75 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06154252A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT05895786A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06916806A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT07085104FT839 in Autoimmune Diseases
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07800871Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT07486869A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT06698796Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT07089121Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT06371417A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT07115745Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ado-2026 · NCT07138898Intralesional Injection of STS in Treatment of Calcinosis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06672822Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Elb-2026 · NCT07160205Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Bit-2026 · NCT02945345Rheumatology Patient Registry and Biorepository
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT04402086A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Gur-2026 · NCT07403188MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 7 fi ol · Saalaa hunda · Haaromfame 28-Ama-2026 · NCT07374107Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 89 · Saalaa hunda · Haaromfame 08-Onk-2025 · NCT06857240Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 25 hanga 72 · Saalaa hunda · Haaromfame 21-Cam-2025 · NCT06298019Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.